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We aimed to determine relations between the sudomotor efferent nerve fiber function and 
Boston questionnaire (BQ) in idiopathic carpal tunnel syndrome (CTS). Median nerve-in­
duced sympathetic skin responses (SSRs) evoked by wrist stimulation were recorded in 108 
CTS patients and compared with those in 88 healthy volunteers. The Boston questionnaire 
form (BQF) was applied to the subjects. All patients and healthy individuals were questioned 
about the autonomic symptoms in the hand (red or purple skin coloration, excessive sweat­
ing, and feeling cold). The average SSR latencies of the patients with CTS were significantly 
longer than those in the control group (P < 0.001). Positive significant, while weak, cor­
relations were found between the SSR latency, autonomic symptoms, and total sympathetic 
system scores. No statistically significant relationship was found between the Boston symp­
tom severity, functional capacity scores, and SSR latency. The latter obtained through wrist 
stimulation was sensitive to support the sudomotor sympathetic dysfunction in patients with 
CTS. No relationship between the BQF and SSR can be related to the fact that these indices 
evaluate different aspects of CTS. 
Keywords: carpal tunnel syndrome, sympathetic skin response, sympathetic activity, 
sudomotor activity, Boston questionnaire. 
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INTRODUCTION
Carpal tunnel syndrome (CTS) is the most frequently 
observed peripheral nerve entrapment neuropathy 
[1]. Although many factors may increase the pressure 
on the median nerve, as it passes through the carpal 
tunnel, idiopathic CTS cases far outnumber all other 
types [1]. Idiopathic CTS often occurs in middle-aged 
women without other known pathologies [2]. 
Median sensory and motor nerve conduction studies 
(NCSs) are valid and reproducible clinical laboratory 
techniques that can confirm clinical diagnosis of 
CTS with a high degree of sensitivity and specificity 
[3]. Autonomic nerve fibers constitute an important 
component in the peripheral nerves [4]. However, only 
the function of myelinated (fast-conducting) fibers 
can usually be examined using NCS; the responses 
of unmyelinated fibers, such as C afferents and 
postganglionic sympathetic fibers, can be detected 
with significant difficulties. 
The sympathetic skin response (SSR) has been 
frequently used in polyneuropathies and dysautonomic 
disorders in the studies carried out upon sympathetic 
fiber functions [5, 6]. In terms of the electrical 
potential of the skin, the SSR is a transient change. It 
can be spontaneous or can also be caused by several 
internal or external stimuli [5]. The SSR was analyzed 
in several studies related to autonomic involvement in 
CTS; however, findings of these studies considerably 
differed from each other [4, 5, 7-11]. Moreover, the 
relationship of the SSR data with clinical scales, 
such as the Boston questionnaire form (BQF) used to 
evaluate the severity of the symptoms and functional 
status in CTS, has not been known. 
The studies searching for the CTS and SSR 
relationship have up to present been carried out with 
maximum 76 patients [10]. In our study, the number 
of patients was greater, and we aimed to clarify the 
controversial CTS-SSR relationship and analyze the 
relationship of SSR data with BQF, which have not 
been evaluated before. 
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METHODS
One hundred-eight patients showing symptoms and 
clinical signs suggesting unilateral or bilateral CTS 
and 88 healthy volunteers were included in the study. 
The study was carried out upon the patients with 
idiopathic CTS. Therefore, the patients with diabetes 
mellitus, rheumatoid arthritis, hypothyroidism, wrist 
fracture, renal failure, and dialysis history were not 
included in the study. Also, the patients with cardiac 
failure, severe hypertension, and hereditary autonomic 
system diseases that can cause involvement of the 
autonomic system were also not examined. Symptoms 
of CTS and data on age, gender, occupation, spare 
time activities, height, and body mass were evaluated, 
and neurological examinations were performed. The 
body mass index (BMI) was calculated as the body 
mass (kg) divided by the square of the height (m) [12]. 
The patients filled the BQF including the “functional 
capacity scale” and “symptom severity scale”. The 
following symptoms related to hands were asked to 
all patients and healthy individuals: red or purple skin 
coloration, excessive sweating, and feeling cold. Any 
of the patients did not have any symptoms or signs of 
a peripheral neuropathy rather than CTS. Points from 
0 to 3 were marked according to the existence of red 
or purple coloration, excessive sweating, or feeling 
cold for the sympathetic symptoms in the symptomatic 
hands of the patients (one point for each symptom) 
[4, 5].
The NCS and SSR recordings were performed 
on the more symptomatic hand, if the patient 
was bilaterally symptomatic for CTS, and on the 
symptomatic hand, if the patient was unilaterally 
symptomatic for this pathology [12, 13]. These 
procedures were also performed on the dominant hand 
in the control group. Diagnosis of CTS was based on 
the practice parameter for electrodiagnostic studies 
established by the American Academy of Neurology, 
American Association of Electrodiagnostic Medicine, 
and American Academy of Physical Medicine and 
Rehabilitation [14].
Before electrophysiological examination, SSR was 
recorded in accordance with the technique described 
by Shahani et al. [15] and Verghese et al. [10]. In order 
to prevent habituation, single 0.1-msec square-wave 
pulses slightly exceeding the motor threshold intensity 
were five times applied with irregular intervals upon 
the median nerve at the wrist level. The obtained 
effects were recorded using standard surface electrodes 
attached to the palmar and dorsal surfaces of the hand. 
The latency was measured with respect to the onset 
of the response (negative or positive deflection), and 
peak-to-peak response amplitudes were estimated. 
Average amplitudes and latencies were also calculated 
from the obtained five records.
The NCS data obtained included the thumb 
(M1), index (M2), and middle (M3) finger sensory 
conduction velocity to the wrist, median distal motor 
latency, and median motor conduction velocity of 
the patients and controls. Patients and controls with 
abnormalities in the ulnar motor nerve and sensory 
conduction were not included in the study.
All recordings were performed on subjects lying 
supine on a bed in an air-conditioned room at room 
temperature of 24°C and avoiding external stimuli. 
The skin temperature during the electrophysiological 
examinations was kept at or above 32°C. Standard 
surface recording and stimulating electrodes were used 
during electrophysiological studies. The Medelec-
Oxford EMG equipment (Great Britain) was used in 
all tests. 
The clinical severity of CTS was assessed according 
to a 6-stage scale: stage 0, no evidence suggesting the 
presence of CTS; stage 1, only nocturnal paresthesias; 
stage 2, diurnal paresthesias; stage 3, sensory deficit; 
stage 4, strength loss in the thenar muscles, and stage 
5, complete atrophy or complete plegia [12, 16, 17]. 
Electrophysiological abnormalities of patients with 
CTS were evaluated on a 5-stage scale: stage 1, 
abnormal results of segmental or comparative studies; 
stage 2, abnormal finger/wrist sensory conduction 
velocities; stage 3, abnormal finger/wrist sensory 
conduction velocities and abnormal distal motor 
latencies; stage 4, absence of the sensory response and 
an abnormal distal motor latency, and stage 5, absence 
of the sensory and motor responses [12, 16-18]. 
Descriptive analysis was performed for the studied 
groups in order to inform on general features of the 
studed groups. For evaluation distributions of the 
variables, the Kolmogorov – Smirnov test was used. 
For comparison of the constant variables in the groups, 
the independent-sample t-test or Mann–Whitney U-test 
were used in the case of normal distributions. For 
comparison of the categorical variables, the χ2 test was 
used. Pearson’s and Spearman’s correlation analyses 
were employed in the analysis of the relationship 
between variables. The data related to the constant 
variables were presented as means ± s.d., and the data 
related to the categorical variables were presented 
as normalized values (%). The P values below 0.05 
were considered indications of statistically significant 
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intergroup differences. The calculations were made 
using statistical software packages, IBM SPSS 
Statistics 20 and SPSS inc. (IBM Co. and Somers, 
USA).
RESULTS
The mean age of 108 patients included in the study 
was 45.96 ± 8.93 years, and the respective value in the 
control group was 43.51 ± 9.48 years. Ninety-seven 
patients (89.8%) were women, and 11 (10.2%) were 
men; in the control group, the respective figures were 
73 (83%) and 15 (17%). There were no significant 
differences between the patient and control groups in 
terms of age and gender (P > 0.05). 
Most examined subjects (87.9% of the CTS patients 
and 78.4% of the control persons) were housewives. 
The most frequently performed leisure activity after 
house works was handworks (29.6% in the patients 
and 53.5% in the control subjects).
In terms of the clinical stage, 33 (30.6%) of the CTS 
patients were at stage 1, 64 (59.3%) were at stage 2, 10 
(9.3%) were at stage 3, and one (0.9%) was at stage 4. 
In terms of the electrophysiological stage, 11 (10.2%) 
patients were at stage 1, 40 (37%) patients were at 
stage 2, 47 (43.5) patients were at stage 3, 5 (4.6%) 
patients were at stage 4, and 5 (4.6%) patients were 
at stage 5. The mean Boston symptom severity score 
of the patients with CTS was 33.03 ± 9.01, and their 
functional capacity score was 23.88 ± 7.25. 
Most (70.4%) of the patients with CTS complained 
about red or purple coloration on their hands, 84.3% 
complained about sweating, and 33.3% complained 
about feeling cold; the respective rates for the 
control group were 20.5, 30.7, and 9.1%. There was 
a statistically significant difference between the 
control and patient groups in terms of these autonomic 
symptoms (P  < 0.001). The average values of 
sympathetic system scores obtained through the total 
of these three complaints were 1.88 ± 0.94 in CTS 
group and 0.59 ± 0.70 in the control group (P < 0.001). 
The mean SSR latency of the patients with CTS was 
1.39 ± 0.18 sec, and in the control group it was 1.25 ± 
± 0.14 sec. the mean SSR latency of the patients with 
CTS was significantly longer than that in the control 
group (P < 0.001). The average SSR amplitude of the 
patients with CTS was 833.9 ± 782.5 µV, and it was 
718.8 ± 439.0 µV in the control group. No statistically 
significant difference was found between the patient 
and control groups in terms of the SSR amplitudes 
(P = 0.823). The SSR could not be obtained in three 
patients.
A positive significant (but weak) correlation was 
estimated between the SSR latency and obtained 
autonomic symptoms and total sympathetic system 
scores (Table 1). The SSR latency was also in a 
positive significant (but also weak) correlation with 
electrophysiological staging of CTS, median nerve 
motor latency, and age (Table 1). No statistically 
significant difference was found between the Boston 
symptom severity, functional capacity scores, and SSR 
latency (Table 1). 
DISCUSSION
In our study, the SSR latencies measured after 
stimulation of the median nerve at the wrist level were 
found to be statistically significantly longer in patients 
T a b l e 1. Correlations between the SSR Latency and Clinical/
Electrophysiological Features in CTS Patients
Кореляції між латентним періодом шкірної симпатичної 
відповіді та клінічними електрофізіологічними 
особливостями у пацієнтів із синдромом зап’ястного каналу
Features SSR latency
r P
Age 0.221 0.024
BMI 0.044 0.656
Mean SSS 0.361 <0.0001
Skin coloration 0.237 0.015
Excessive sweating 0.308 0.001
Feeling cold 0.254 0.009
DML–M 0.276 0.005
MCV–M –0.165 0.097
M1 SCV –0.148 0.148
M2 SCV –0.085 0.406
M3 SCV –0.084 0.413
Clinical severity scores 0.186 0.059
Electrophysiological 
severity scores
0.272 0.005
BSSS –0.034 0.734
BFCS 0.028 0.783
Foonotes. BMI, body mass index; SSS, sympathetic symptom 
score; M1–M3, conductions, thumb to wrist (M1), index finger 
to wrist (M2), and middle finger to wrist (M3); SCV, sensory 
conduction velocity; DML-M, median distal motor latency; 
MCV-M, median motor conduction velocity; BSSS, Boston 
symptom severity score, and BFCS, Boston functional capacity 
score. P values shown in bold indicate cases of statistical 
significance of correlation.
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with CTS than those in the control group; beside 
this, the SSR latencies were found to correlate with 
the intensity of autonomic symptoms. The findings 
obtained earlier in the SSR studies on patients with 
CTS were not consistent with each other [4, 5, 7-11]. 
Verghese et al. [10] using the same technique in 76 
patients with CTS reported that SSR abnormality 
significantly correlated with the presence of autonomic 
symptoms, and the latter significantly correlated with 
the severity of electrophysiological abnormality. 
Reddeppa et al. [9] observed abnormalities in the SSR 
values in 30 patients with CTS who had no serious 
autonomic disorders. Kanzato et al. [7] recorded SSRs 
simultaneously from four different points. Electrodes 
were placed on the palmar surface of the hand; at the 
wrist level (W) at the metacarpo-phalangeal joint (J), 
on the middle phalanx (M), and on the distal phalanx 
(D) of the index finger. At all recording sites except 
of point D, the SSR amplitude in normal hands was 
significantly higher than this parameter in CTS 
patients. A weak but significant correlation was clear 
between the SSR amplitude at points W and J and the 
clinical grade [7]. 
In the study of Bayrak et al. [5], the SSR was evoked 
by suprasternal stimulation in 50 hands of 31 patients 
and 50 hands of 25 healthy controls. The groups were 
investigated in terms of the sympathetic symptoms, 
and sympathetic system scores (SSS) were calculated. 
Although there was no significant difference between 
the groups in terms of SSS values, there was also no 
difference in terms of the SSR. No relationship was 
found between the SSR and SSS parameters and the 
electrophysiological stage. The authors, therefore, 
did not recommend SSR recording as a sensitive 
method to evaluate autonomic involvement in CTS 
[5]. Sener et al. [4] recorded the median and ulnar 
SSRs by stimulating the sternum in 31 patients with 
CTS comparing the findings with those in 21 healthy 
controls. It was reported that the SSR was not sensitive 
to reveal sudomotor sympathetic dysfunction even in 
the patients with autonomic symptoms of CTS. As 
in the study by Sener et al. [4], peripheral effects of 
the somatic fiber involvement might be neglected 
by giving suprasternal stimulation. In the study of 
Zyluk and Kosovets [11], bilateral capillaroscopy and 
sternally stimulated SSRs were performed in patients 
with unilateral CTS, and no significant difference was 
found between the SSR parameters and capillaroscopy 
values in affected and unaffected hands. 
In examination of the SSRs, there is no agreement in 
the recording methods or in attention to different SSR 
parameters (the mean or the shortest latency, the mean 
amplitude or the area, etc.) [8]. Therefore, it is difficult 
to compare the results of the above-cited SSR studies. 
Kiylioglu et al. [8] mentioned that the discrepancies 
might be caused by the use of different stimulation and 
recording methods. The common point in these studies 
is the following. As the distance between the recording 
and stimulation points increases, the possibility for 
identification of an abnormality decreases [7].
The polysynaptic reflex arc for the SSR contains 
large myelinated afferent sensory fibers, central 
relays localized in the posterior hypothalamus and/or 
upper brainstem reticular formation, and an efferent 
pathway through the spinal cord, sympathetic 
preganglionic fibers, and postganglionic nerve 
fibers, with sweat glands as crucial effectors [8]. 
Certain changes have been expected in CTS because 
postganglionic unmyelinated C fibers are present 
in the median nerve [5, 8]. Myelinated nerve fibers 
are less resistant to compression than unmyelinated 
ones. The latter can be damaged by prolonged local 
compressions, and patients in chronic stages can have 
obvious autonomic symptoms [5]. For this reason, a 
statistically significant positive relationship was found 
with the SSR latency in EMG stages. 
Autonomic symptoms have not been encountered 
at a rare rate in patients with CTS. In the study of 
Verghese et al. [10], 57% (43 limbs) of the patients in 
the symptomatic group had one autonomic symptom, 
and 43% (33 limbs) had two or more such symptoms 
in the above group. In the cited study, as in ours, 
autonomic symptoms were significantly associated 
with the severity of electrophysiological abnormalities 
but not with the clinical severity [10]. We, however, 
could not find a relationship in terms of the female 
gender and the presence of autonomic disorders. In 
the study by Sener et al. [4], the mean sympathetic 
symptom score was 1.1 ± 0.15. Skin coloration, 
excessive sweating, and feeling cold scores were 0.36 ± 
± 0.08, 0.46 ± 0.08, and 0.26 ± 0.07, respectively [4]. 
In our patients, the mean SSS was 1.88 ± 0.94. 
The Boston questionnaire form was developed by 
Levine et al. [19] in 1993. It allows the patient to 
evaluate the symptoms and functional status. In 2001, 
this form was translated into Turkish by Heybeli et 
al. [20], and its validity was preliminarily confirmed. 
In 2006, the Turkish version of BQF was found to 
be reliable and valid by Sezgin et al. [21]. It cannot, 
however, distinguish other neuropathies and disorders 
affiliated to upper extremity diseases from CTS. In 
the literature, there is a limited number of studies 
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analyzing the relationship between the Boston scores 
and median nerve conduction characteristics. Akman 
et al. [22] reported that there is good correlation 
between the BQF and median nerve characteristics. 
The authors suggested that only BQF application 
would be adequate in postoperative evaluation, and 
additional EMG analysis in asymptomatic patients 
increased the cost. Because an invasive analysis 
technique should be used in this case, it imposed an 
additional load for the patients [22]. Heybeli et al. [20] 
and Mondelli et al. [18] found no relationship between 
the Boston scores and median nerve conduction and 
tried to explain the reason of this finding. Heybeli et 
al. [23] mentioned that only the research-purpose use 
of the BQF was appropriate; Mondelli et al. [18] stated 
that electrophysiological tests and BQF should be used 
together for the CTS monitorization. In our study, no 
significant relationship was also found between the 
SSR parameters and BQF. The reason for this can 
be the following: the BQF and SSR testing evaluate 
different aspects of CTS, as was also mentioned by the 
above authors.
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Р е з ю м е
Ми намагалися встановити взаємовідносини судомотор­
ної функції еферентного нерва та показників Бостонсько­
го опитувальника (BQ) у випадках ідіопатичного синдро­
му зап’ястного каналу (СЗК). Шкірні симпатичні відповіді 
(ШСВ) відводилися після стимуляції медіанного нерва на 
рівні зап’ястка у 108 пацієнтів із діагностованим СЗК; ці 
характеристики порівнювались із такими у 88 здорових до­
бровольців. Усім суб’єктам пропонували форму BQF. Усі 
пацієнти та здорові особи опитувалися щодо вегетативних 
симптомів, які проявлялися на кисті (червоне або пурпурове 
забарвлення шкіри, надмірне потовиділення та відчуття хо­
лоду). Середнє значення латентного періоду ШСВ у пацієн­
тів із СЗК вірогідно перевищувало таке в контрольній групі 
(P < 0.001). Істотна позитивна, хоча й слабка, кореляція 
була виявлена між латентним періодом ШСВ, вегетативни­
ми симптомами та бальною загальною оцінкою стану сим­
патичної системи. Не було встановлено вірогідних відно­
син між показником тяжкості симптомів (згідно з BQF), 
оцінкою функціональної здатності та латентним періодом 
ШСВ. Останній параметр, отриманий при стимуляції на рів­
ні зап’ястка, був чутливим щодо судомоторної симпатич­
ної дисфункції у пацієнтів із цим синдромом. Відсутність 
зв’язку між оцінками BQF та ШСВ може бути зумовлена 
тим, що дані показники оцінюють різні аспекти ШСВ. 
REFERENCES
1. Sh. J. Oh, Clinical Electromyography. Nerve Conduction 
Studies, Lippincott Williams & Wilkins, Philadelphia (2003).
2. Y. Kaplan, S. G. Kurt, and H. Karaer, “Carpal tunnel syndrome 
in postmenopausal women,” J. Neurol. Sci., 270, Nos. 1/2, 77-
81 (2008). 
3. C. K. Jablecki, M. T. Andary, Y. T. So, et al., “Literature 
review of the usefulness of nerve conduction studies and 
electromyography for the evaluation of patients with carpal 
tunnel syndrome. AAEM Quality Assurance Committee,” 
Muscle Nerve, 16, No. 12, 1392-1414 (1993).
4. H. O. Sener, N. F. Taşcilar, H. Balaban, and D. Selçuki, 
“Sympathetic skin response in carpal tunnel syndrome,” Clin. 
Neurophysiol., 111, No. 8, 1395-1399 (2000).
5. A. O. Bayrak, H. E. Tilki, and M. Coşkun, “Sympathetic skin 
response and axon count in carpal tunnel syndrome,” J. Clin. 
Neurophysiol., 24, No. 1, 70-75 (2007).
6. Z. Ming, J. Siivola, S. Pietikainen, et al., “Postoperative 
relieve of abnormal vasoregulation in carpal tunnel syndrome,” 
Clin. Neurol., Neurosurg., 109, No. 5, 413-417 (2007).
7. N. Kanzato, Y. Komine, F. Kanaya, and K. Fukiyama, 
“Preserved sympathetic skin response at the distal phalanx in 
patients with carpal tunnel syndrome,” Clin. Neurophysiol., 
111, No. 11, 2057-2063 (2000).
8. N. Kiylioglu, A. Akyol, E. Guney, et al., “Sympathetic skin 
response in idiopathic and diabetic carpal tunnel syndrome,” 
Clin. Neurol., Neurosurg., 108, No. 1, 1-7 (2005).
9. S. Reddeppa, K. Bulusu, P. R. Chand, et al., “The sympathetic 
skin response in carpal tunnel syndrome,” Auton. Neurosci., 
84, No. 3, 119-121 (2000).
10. J. Verghese, A. S. Galanopoulou, and S. Herskovitz, 
“Autonomic dysfunction in idiopathic carpal tunnel syndrome,” 
Muscle Nerve, 23, No. 8, 1209-1213 (2000).
11. A. Zyluk and L. Kosovets, “An assessment of the sympathetic 
function within the hand in patients with carpal tunnel 
syndrome,” J. Hand. Surg. Eur., 35, No. 5, 402-408 (2010). 
12. S. Kurt, B. Kisacik, Y. Kaplan, et al., “Obesity and carpal 
tunnel syndrome: is there a causal relationship?” Eur. Neurol., 
59, No. 5, 253-257 (2008). 
NEUROPHYSIOLOGY / НЕЙРОФИЗИОЛОГИЯ.—2016.—T. 48, № 3 217
SYMPATHETIC SKIN RESPONSE AND BOSTON QUESTIONNAIRE
13. L. Padua, P. Pasqualetti, and R. Rosenbaum, “One patient, two 
carpal tunnels: statistical and clinical analysis – by hand or by 
patient?” Clin. Neurophysiol., 116, No. 2, 241-243 (2005).
14. “Practice parameter for electrodiagnostic studies in carpal 
tunnel syndrome (summary statement),” Neurology, 43, 
No. 11, 2404-2405 (1993).
15. B. T. Shahani, J. H. Halperin, P. Boulu, and J. Cohen, 
“Sympathet ic  skin response-a method of  assessing 
unmyelinated axon dysfunction in peripheral neuropathies,” J. 
Neurol., Neurosurg., Psychiat., 47, No. 5, 536-542 (1984).
16. F. Giannini, R. Cioni, M. Mondelli, et al., “A new clinical scale 
of carpal tunnel syndrome: validation of the measurement and 
clinical-neurophysiological assessment,” Clin. Neurophysiol., 
113, No. 1, 71-77 (2002).
17. M. Mondelli, S. Passero, and F. Giannini, “Provocative tests 
in different stages of carpal tunnel syndrome,” Clin. Neurol., 
Neurosurg., 103, No. 3, 178-183 (2001).
18. M. Mondelli, F. Reale, F. Sicurelli, and L. Padua, “Relationship 
between the self-administered Boston questionnaire and 
electrophysiological findings in follow-up of surgically-treated 
carpal tunnel syndrome,” J. Hand. Surg. Br., 25, No. 2, 128-
134 (2000).
19. D. W. Levine, B. P. Simmons, M. J. Koris, et al., “A self-
administered questionnaire for the assessment of severity of 
symptoms and functional status in carpal tunnel syndrome,” J. 
Bone Joint Surg. Am., 75, No. 11, 1585-1592 (1993).
20. N. Heybeli ,  R. A. Ozerdemoglu, O. G. Aksoy, and 
E. F. Mumcu, “Functional and symptomatic scoring used for 
the assessment of outcome in carpal tunnel release,” Acta. 
Orthop., Traumatol. Turc., 35, No. 2, 147-151 (2001).
21. M. Sezgin, N. A. Incel, S. Serhan, et al., “Assessment of 
symptom severity and functional status in patients with carpal 
tunnel syndrome: reliability and functionality of the Turkish 
version of the Boston Questionnaire,” Disabil. Rehabil., 28, 
No. 20, 1281-1285 (2006).
22. S. Akman, E. Erturer, M. Celik, et al., “The results of open 
surgical release in carpal tunnel syndrome and evaluation of 
follow-up criteria,” Acta. Orthop., Traumatol. Turc., 36, No. 3, 
259-264 (2002).
23. N. Heybeli, S. Kutluhan, S. Demirci, et al., “Assessment 
of outcome of carpal tunnel syndrome: a comparison of 
electrophysiological findings and a self-administered Boston 
questionnaire,” J. Hand. Surg. Br., 27, No. 3, 259-264 (2002).
